Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Gene involved in colon cancer development revealed

Aug. 30, 1996

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Cancer genetics joint venture

Aug. 30, 1996

Inflazyme/SuperGen future licensing agreement

Aug. 30, 1996

Conjugates for cancer/infectious disease treatment covered by U.S. patent

Aug. 30, 1996

LGD-1069 to enter pivotal U.S. trials

Aug. 30, 1996

AG-2034 granted approval for U.S. phase I initiation

Aug. 30, 1996

Phase III trial on Onconase combination initiated

Aug. 30, 1996

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996

Lisofylline undergoes phase III in cancer patients

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...